Cardiovascular disease is the #1 cause of disability and death for people with diabetes1

1 in 3 patients with T2D have established CVD2

9 of 10 patients with T2D and established CVD have ASCVD2*

Only 2 in 10 patients with T2D are prescribed a glucose-lowering treatment with a proven CVD benefit3†

*ASCVD includes cerebrovascular disease, carotid artery disease, coronary heart disease or peripheral arterial disease. 
†Glucose-lowering treatments with proven CVD benefit include certain GLP-1 RAs and SGLT-2is.

 

Elevate the Connection

1.

Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus. Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus—mechanisms, management, and clinical considerations. Circulation. 2016;133(24):2459-2502.

2.

Mosenzon O, Alguwaihes A, Arenas Leon JL, et al. CAPTURE: a cross-sectional study of the contemporary (2019) prevalence of cardiovascular disease in adults with type 2 diabetes across 13 countries. Presented at the 56th Annual Meeting of the European Association of the Study of Diabetes, Macrovascular complications and beyond. January 18, 2021. Abstract 158.

3.

Vencio S, Alguwaihes A, Arenas Leon JL, et al. Contemporary use of diabetes medications with a cardiovascular indication in adults with type 2 diabetes: a secondary analysis of the multinational CAPTURE study. Presented at the 56th Annual Meeting of the European Association of the Study of Diabetes, Cardiovascular complications in humans through and through. January 18, 2021. Abstract 945.

4.

Dal Canto E, Ceriello A, Rydén L, et al. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26(2):25-32.

5.

Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes. 2014;5(4):444-470.

6.

American Diabetes Association. Standards of medical care in diabetes—2021. Diabetes Care. 2021;44(suppl1):S111-S124

7.

Halter JB, Musi N, McFarland Horne F, et al. Diabetes and cardiovascular disease in older adults: current status and future directions. Diabetes. 2014;63(8):2578-2589.

8.

Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018;17(1):83. doi:10.1186/s12933-018-0728-6

9.

Nichols GA, Rosales AG, Perrin NA, Fortmann SP. The association between different A1C-based measures of glycemia and risk of cardiovascular disease hospitalization. Diabetes Care. 2014;37(1):167-172.